Literature DB >> 4742739

Oxygen affinity and electrolyte distribution of human blood: changes induced by propranolol.

A Agostoni, C Berfasconi, G C Gerli, M Luzzana, L Rossi-Bernardi.   

Abstract

Propranolol causes a massive leakage of potassium ions from red cells, which results in an alteration of the Gibbs-Donnan equilibrium across the red cell membrane. According to such a mechanism, the presence of propranolol significantly increases the hydrogen ion activity of the interior of the red cell, causing a decreased oxygen affinity of hemoglobin according to the classical Bohr effect. No release of 2,3-diphosphoglycerate which may be bound to the membrane is thus necessary to explain the effect of propranolol on the oxygen dissociation curve of blood.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4742739     DOI: 10.1126/science.182.4109.300

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Effect of methylene blue on P50 and 2,3DPG of human blood in vitro.

Authors:  C Bernasconi; G C Gerli; R Stabilini; A Agostoni
Journal:  Experientia       Date:  1974-06-15

2.  Lack of influence of short-term treatment with propranolol and terbutaline on metabolism and energy expenditure of the Na-K pump in human erythrocytes evaluated by microcalorimetry.

Authors:  B Fagher; H Liedholm; M Monti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  The action of propranolol on factors concerned with the delivery of oxygen to the tissues.

Authors:  J M Ledingham; D C Lees
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

4.  Acute effects of propranolol on the circulation and on oxygen uptake in conscious rats.

Authors:  J M Ledingham; D C Lees
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

5.  Oxyhaemoglobin equilibrium and chronic beta-adrenoceptor blockade in coronary heart disease.

Authors:  H J Jürgensen; P D Wimberley; U Brodthagen
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.